fda d.i.s.c.o.: burst edition: fda approval of pluvicto (lutetium lu 177 vipivotide tetraxetan) f...
Published 5 months ago • 52 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
10:07
new fda approved: pluvicto (lutetium-177) for advanced prostate cancer | mark scholz, md | pcri
-
7:09
177 lu psma treatment for prostate cancer (update: fda approved on 3/23/22)
-
4:44
fda approves new diagnostic that can help beat prostate cancer
-
3:45
new prostate cancer tracer approved by fda
-
7:09
prostate cancer clinical trials with pluvicto
-
5:03
johnson & johnson (jnj) wins first-ever fda approval for non-chemo treatment of lung cancer
-
59:02
radioligand therapy virtual townhall 2024
-
9:33
precision guided focal therapy for prostate cancer
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
15:35
lu-psma radioligand therapy
-
11:49
lutetium-177 (pluvicto) vs. psma-actinium | #markscholzmd #alexscholz #pcri
-
14:39
new fda approved parp inhibitor: talzenna (talazoparib) & xtandi | #markscholzmd #alexscholz #pcri
-
0:29
fda approves new cancer drug
-
1:58
fda approves new cancer drug that's already showing promise
-
1:39
zero's ceo on fda's approval of new prostate cancer treatment
-
1:36
fda approves bayer's nubeqa (darolutamide) for non-metastatic castration-resistant prostate cancer
-
4:21
renowned purdue researcher earns another fda approval
-
0:31
preview: fda approval and priority review in ovarian cancer, end of part b payment model, and more
-
2:11
fda approves immunotherapy cancer drug
-
2:09
[bio news] hanmi, approval of fda !
-
1:49
fda approval of durvalumab for bladder cancer
-
0:48
fda approves groundbreaking cancer drug